Syrian opposition forces claimed to have taken control of the eastern Syrian city of Deir ez-Zor. According to Al Jazeera and Arabiya TV, on the 10th local time, Hassan Abdel Ghani, commander of Syrian opposition forces, said that "the eastern Syrian city of Deir ez-Zor has been completely controlled".The onshore RMB against the US dollar officially closed at 7.2590 at 16:30 Beijing time, down 97 points from the official closing price of the previous trading day and down 99 points from the closing price of the previous day and night.Tang Shikai, a member of the board of directors of Mercedes-Benz, will retire next year and is now in charge of the company's business in Greater China. Mercedes-Benz Group Co., Ltd. announced that Hubertus Troska, the current member of the board of directors in charge of the company's business in Greater China, will retire in 2025 as planned. He himself decided to take up a new position as a member of the board of directors of Mercedes-Benz Group Co., Ltd. and a special representative for China affairs from February 1, 2025 to promote the company's business system in the world's largest market. Tang Shikai will officially retire on July 31, 2025.
Guosen Securities: The public offering of corporate bonds to professional investors was approved by the China Securities Regulatory Commission. Guosen Securities announced that the company had received the approval of the China Securities Regulatory Commission to publicly issue corporate bonds with a total face value not exceeding 20 billion yuan to professional investors. This issuance of corporate bonds shall be conducted in strict accordance with the prospectus submitted to Shenzhen Stock Exchange. The reply shall be valid within 24 months from the date of consent to registration, and the company may issue corporate bonds in installments within the validity period of registration.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.SpaceX is valued at about $350 billion due to internal stock sales. According to an email sent to employees seen by the media, SpaceX and its investors have agreed to acquire the company's common stock of up to $1.25 billion at a price of $185 per share. This transaction values the rocket and satellite manufacturer owned by elon musk at about $350 billion.
Guohai Securities gave Youyou Food Co., Ltd. the initial rating of buying.Analyst: There may be a RRR cut of 50 basis points to 100 basis points next year. Tan Yiming, chief fixed income analyst of Minsheng Securities, said that there may be a RRR cut of 50 basis points to 100 basis points next year, considering the supply pressure of government bonds, the restoration of credit supply and the provision of long-term stable low-cost funds for financial institutions.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14